Hybrid Conferencee

International Conference on Hematology and Rare Blood Disorders (ICHRBD - 26)

6th - 7th October 2026 | Toronto, Canada

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Toronto. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Toronto event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Toronto conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Toronto, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Toronto."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Molecular Diagnostics for Hematological Disorders

This track will explore the latest innovations in molecular diagnostic techniques that enhance the detection and characterization of rare blood disorders. Emphasis will be placed on the integration of genomic technologies and their implications for personalized medicine.

Track 02

Clinical Research in Rare Hematological Conditions

This session will focus on recent clinical trials and studies that aim to improve understanding and treatment of rare hematological disorders. Participants will discuss methodologies, outcomes, and the challenges faced in conducting research in this niche area.

Track 03

Translational Research in Hematology

This track will highlight the transition of laboratory findings into clinical applications for hematological disorders. Discussions will center on collaborative efforts between researchers and clinicians to bridge the gap between bench and bedside.

Track 04

Innovative Therapeutic Strategies for Blood Disorders

This session will examine cutting-edge therapeutic approaches, including novel drug developments and treatment protocols for rare blood disorders. Experts will share insights on efficacy, safety, and patient outcomes associated with these strategies.

Track 05

Biomarker Discovery in Hematology

This track will delve into the identification and validation of biomarkers that facilitate early diagnosis and treatment response monitoring in hematological disorders. The focus will be on the role of biomarkers in enhancing patient care and therapeutic decision-making.

Track 06

Laboratory Innovations in Hematology

This session will showcase the latest technological advancements in laboratory practices that improve the diagnosis and management of blood disorders. Attendees will learn about automation, quality control, and novel assays that enhance laboratory efficiency.

Track 07

Patient Care Models for Rare Blood Disorders

This track will discuss comprehensive patient care models that address the unique needs of individuals with rare hematological conditions. Emphasis will be placed on multidisciplinary approaches and patient-centered care strategies.

Track 08

Understanding Disease Mechanisms in Hematology

This session will focus on the underlying biological mechanisms that contribute to the pathogenesis of rare blood disorders. Researchers will present findings that elucidate genetic, environmental, and molecular factors influencing disease development.

Track 09

Ethical Considerations in Hematology Research

This track will address the ethical challenges and considerations inherent in conducting research on rare blood disorders. Discussions will include informed consent, patient privacy, and the implications of genetic testing.

Track 10

Global Perspectives on Hematology and Rare Disorders

This session will provide insights into the global burden of hematological disorders and the disparities in access to care and treatment. Participants will discuss international collaborations and initiatives aimed at improving outcomes for affected populations.

Track 11

Future Directions in Hematology Research

This track will explore emerging trends and future directions in hematology research, including the potential impact of artificial intelligence and big data. Experts will discuss how these advancements could shape the landscape of diagnosis and treatment in the coming years.